Highly effective use of aprepitant in an adolescent girl with severe cyclic vomiting syndrome
Maria Nivatsi +2 more
openalex +2 more sources
Analyzing adverse event signals of aprepitant using FAERS database data in real-world settings: Broadening the adverse event spectrum of aprepitant and its clinical implications. [PDF]
Chen F, Cai D, Wen H, Zhang L.
europepmc +1 more source
Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy‐induced nausea and vomiting [PDF]
Sant P. Chawla +10 more
openalex +1 more source
Comparison of aprepitant, dexamethasone, and ondansetron with dexamethasone and ondansetron for prevention of postoperative nausea and vomiting in high-risk patients undergoing laparoscopic surgeries: a randomized controlled trial in India. [PDF]
Bala S +5 more
europepmc +1 more source
Aprepitant use during chemotherapy and association with survival in women with early breast cancer. [PDF]
Botteri E +10 more
europepmc +1 more source
Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy [PDF]
core +1 more source
76 Case report: use of long term aprepitant as a treatment for refractory nausea following oesophageal stent insertion [PDF]
Richard Shoulder +2 more
openalex +1 more source
Three are better than two: redefining prophylaxis for postoperative nausea and vomiting. [PDF]
Kang H.
europepmc +1 more source

